Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-07-29 to 2022-08-19
Current total value of award: $957
Description: 4558010731!ZOLADEX 3.6 MG IMPLANT SYRNS